In conclusion, the data presented herein reveal a new facet of LCN2, the obesity-associated adipokine, as a catabolic factor in bone that is regulated in osteoblasts by inflammatory, catabolic, and anabolic factors. Here, LCN2 is linked to obesity disorder.